Critical pertussis illness in children: A multicenter prospective cohort study

Pediatric Critical Care Medicine

Volumn 14, Issue 4, 2013, Pages 356-365

  Berger, John T ^a   Carcillo, Joseph A ^b   Shanley, Thomas P ^c   Wessel, David L ^a   Clark, Amy ^d   Holubkov, Richard ^d   Meert, Kathleen L ^e   Newth, Christopher J L ^f   Berg, Robert A ^g   Heidemann, Sabrina ^e   Harrison, Rick ^h   Pollack, Murray ⁱ   Dalton, Heidi ⁱ   Harvill, Eric ^j   Karanikas, Alexia ^j   Liu, Teresa ^d   Burr, Jeri S ^d   Doctor, Allan ^k   Dean, J Michael ^d   Jenkins, Tammara L ^l   Nicholson, Carol E ^l   more..

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h MATTEL CHILDREN S HOSPITAL   (United States)

ⁱ PHOENIX CHILDREN'S HOSPITAL   (United States)

^j PENNSYLVANIA STATE UNIVERSITY   (United States)

^k ST LOUIS CHILDREN S HOSPITAL   (United States)

^l EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

Intensive care; Leukocyte reduction procedures; Outcome; Pertussis; Pulmonary hypertension; Respiratory failure

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CRITICAL ILLNESS; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SURVIVOR;

BRADYCARDIA; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; PNEUMONIA; PREMATURE BIRTH; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SURVIVAL RATE; UNITED STATES; WHOOPING COUGH;

EID: 84877731671     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31828a70fe     Document Type: Article

References (41)

1. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1424-1426
2. Healy CM, Rench MA, Baker CJ: Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis 2011; 52:157-162
3. Skowronski DM, Janjua NZ, Tsafack EP, et al: The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012; 54:318-327
4. Rohani P, Drake JM: The decline and resurgence of pertussis in the US. Epidemics 2011; 3:183-188
5. Gillis J, Grattan-Smith T, Kilham H: Artificial ventilation in severe pertussis. Arch Dis Child 1988; 63:364-367
6. Surridge J, Segedin ER, Grant CC: Pertussis requiring intensive care. Arch Dis Child 2007; 92:970-975
7. Namachivayam P, Shimizu K, Butt W: Pertussis: Severe clinical presentation in pediatric intensive care and its relation to outcome. Pediatr Crit Care Med 2007; 8:207-211
8. Mikelova LK, Halperin SA, Scheifele D, et al: Predictors of death in infants hospitalized with pertussis: A case-control study of 16 pertussis deaths in Canada. J Pediatr 2003; 143:576-581
9. Pierce C, Klein N, Peters M: Is leukocytosis a predictor of mortality in severe pertussis infection? Intensive Care Med 2000; 26:1512-1514
10. Haberling DL, Holman RC, Paddock CD, et al: Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J 2009; 28:194-198
11. Burr JS, Jenkins TL, Harrison R, et al: The Collaborative Pediatric Critical Care Research Network Critical Pertussis Study: Collaborative research in pediatric critical care medicine. Pediatr Crit Care Med 2011; 12:387-392
12. Riffelmann M, Wirsing von König CH, Caro V, et al: Nucleic Acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005; 43:4925-4929
13. Templeton KE, Scheltinga SA, van der Zee A, et al: Evaluation of realtime PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol 2003; 41:4121-4126
14. Lubchenco LO, Hansman C, Dressler M, et al: Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation. Pediatrics 1963; 32:793-800
15. Martin JA, Hamilton BE, Sutton PD, et al: Births: Final data for 2008. Natl Vital Stat Rep 2010; 59:1
16. Vitek CR, Pascual FB, Baughman AL, et al: Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003; 22:628-634
17. Du JB, Li SZ, Wang BL, et al: Doppler echocardiographic evaluation of pulmonary artery pressure in pneumonia of infants and children. Pediatr Pulmonol 1991; 10:296-298
18. Uner A, Caksen H, Arslan S, et al: Doppler echocardiographic evaluation of pulmonary artery pressure in children with acute pneumonia. Acta Paediatr Taiwan 2002; 43:10-14
19. Paddock CD, Sanden GN, Cherry JD, et al: Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47:328-338
20. Sawal M, Cohen M, Irazuzta JE, et al: Fulminant pertussis: A multicenter study with new insights into the clinico-pathological mechanisms. Pediatr Pulmonol 2009; 44:970-980
21. Rowlands HE, Goldman AP, Harrington K, et al: Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants. Pediatrics 2010; 126:e816-e827
22. Guiso N: Bordetella pertussis and pertussis vaccines. Clin Infect Dis 2009; 49:1565-1569
23. Mattoo S, Cherry JD: Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326-382
24. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003; 21:335-376
25. Caroff M, Deprun C, Richards JC, et al: Structural characterization of the lipid A of Bordetella pertussis 1414 endotoxin. J Bacteriol 1994; 176:5156-5159
26. Cornell TT, Wynn J, Shanley TP, et al: Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics 2010; 125:1248-1258
27. Dunne A, Ross PJ, Pospisilova E, et al: Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol 2010; 185:1711-1719
28. Andreasen C, Powell DA, Carbonetti NH: Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One 2009; 4:e7079
29. Higgins SC, Jarnicki AG, Lavelle EC, et al: TLR4 mediates vaccineinduced protective cellular immunity to Bordetella pertussis: Role of IL-17-producing T cells. J Immunol 2006; 177:7980-7989
30. Mann PB, Wolfe D, Latz E, et al: Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun 2005; 73:8144-8152
31. Wolfe DN, Mann PB, Buboltz AM, et al: Delayed role of tumor necrosis factor-alpha in overcoming the effects of pertussis toxin. J Infect Dis 2007; 196:1228-1236
32. Corbett NP, Blimkie D, Ho KC, et al: Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS One 2010; 5:e15041
33. McGuirk P, McCann C, Mills KH: Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195:221-231
34. Byrne P, McGuirk P, Todryk S, et al: Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 2004; 34:2579-2588
35. Hickey FB, Brereton CF, Mills KH: Adenylate cyclase toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activationand IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J Leukoc Biol 2008; 84:234-243
36. Higgins SC, Lavelle EC, McCann C, et al: Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 2003; 171:3119-3127
37. McGuirk P, Mills KH: Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol 2000; 30:415-422
38. Ross PJ, Lavelle EC, Mills KH, et al: Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun 2004; 72:1568-1579
39. Hall MW, Knatz NL, Vetterly C, et al: Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 2011; 37:525-532
40. Aaby P, Benn C, Nielsen J, et al: Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sexdifferential effects on child survival in high-mortality countries. BMJ Open 2012; 2:e000707
41. Ulloa-Gutierrez R, Avila-Aguero ML: Pertussis in Latin America: Current situation and future vaccination challenges. Expert Rev Vaccines 2008; 7:1569-1580